Company / Goodwill
Bristol Myers Squibb Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$21.8B
FY2025
5-year range
$20.5B / $21.8B
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#4 of 74
Health Care
What the data says
Among 74 Health Care companies, Bristol Myers Squibb is in the top 5% for goodwill. Goodwill has increased for 3 consecutive years, from $20.5B in FY2022 to $21.8B in FY2025.
Based on SEC 10-K filings.
$21.8B in FY2025 with a 5-year CAGR of +1.1%. Top quartile in the Health Care sector.
Improved from $21.1B to $21.8B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +2.0%
- 5-Year CAGR
- +1.1%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 74This company $21.8B Sector average $4.0B
▼
+441.6% above sector average
Key checks
Key Insights
- Bristol Myers Squibb's goodwill has grown for 3 consecutive years.
- 5-year CAGR of +1.1%, indicating consistent growth.
- In FY2025, goodwill increased 0.2% year-over-year.
- Ranks #4 out of 74 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.8B | +0.2% |
| FY2024 | $21.7B | +2.7% |
| FY2023 | $21.1B | +3.2% |
| FY2022 | $20.5B | -0.2% |
| FY2021 | $20.5B | +0.0% |
| FY2020 | $20.5B | -8.6% |
| FY2019 | $22.5B | +244.0% |
| FY2018 | $6.5B | -4.7% |
| FY2017 | $6.9B | -0.2% |
| FY2016 | $6.9B | -0.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026